Cargando…
Use of a Silver-Impregnated Vascular Graft: Single-Center Experience
Introduction: Vascular graft infection is a life threatening situation with significant morbidity and mortality. Bacterial graft infection can lead to false aneurysms, bleeding and sepsis. There are a lot of risky situations where grafts can become infected. It is therefore highly desirable to have...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8944627/ https://www.ncbi.nlm.nih.gov/pubmed/35326849 http://dx.doi.org/10.3390/antibiotics11030386 |
_version_ | 1784673762444050432 |
---|---|
author | Molacek, Jiri Treska, Vladislav Houdek, Karel Opatrný, Václav Certik, Bohuslav Baxa, Jan |
author_facet | Molacek, Jiri Treska, Vladislav Houdek, Karel Opatrný, Václav Certik, Bohuslav Baxa, Jan |
author_sort | Molacek, Jiri |
collection | PubMed |
description | Introduction: Vascular graft infection is a life threatening situation with significant morbidity and mortality. Bacterial graft infection can lead to false aneurysms, bleeding and sepsis. There are a lot of risky situations where grafts can become infected. It is therefore highly desirable to have a vascular graft that is resistant to infection. In this retrospective clinical study, a silver-impregnated vascular graft was evaluated in various indications. Methods: Our study included a total of 71 patients who received a silver-impregnated vascular graft during the period from 2013 to 2018. Patients had an aortoiliac localization of vascular graft in 61 cases (86%), and a peripheral localization on the lower limbs in 10 cases (14%). Indications for the use of these special vascular grafts were trophic lesions or gangrene in the lower limbs in 24 cases (34%), suspicious mycotic abdominal aortic aneurysm (mAAA) in 4 cases (5.5%), salmonela aortitis or aneurysms in 4 cases (5.5%), infection of the previous vascular graft in 11 cases (15.5%), other infections in 12 cases (17%), AAA rupture in 10 cases (14%) and other reasons (pre-transplant condition, multiple trauma, graft-enteric fistula) in 6 cases (8.5%). Thirty-day mortality, morbidity, the need for reintervention and amputation, primary and secondary graft patency, and finally the presence of a proven vascular graft infection were evaluated. Results: The 30-day mortality was 19.7%, and morbidity was 42.2%. The primary patency of the vascular graft was 91.5%. Reoperation was necessary in 10 cases (14%) and amputation was necessary in 10 cases (14%). The median length of hospital stay was 13 days and the mean follow-up period was 48 ± 9 months. During the follow-up period, six patients (8.5%) died from reasons unrelated to surgery or without any relation to the vascular graft. Secondary patency after one year was 88%. Infection of the silver graft was observed in three patients (4.2%). Conclusions: Based on our results, the silver graft is a very suitable alternative for solving infectious, or potentially infectious, situations in vascular surgery. In particular, in urgent or acute cases, a silver graft is often the only option. |
format | Online Article Text |
id | pubmed-8944627 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-89446272022-03-25 Use of a Silver-Impregnated Vascular Graft: Single-Center Experience Molacek, Jiri Treska, Vladislav Houdek, Karel Opatrný, Václav Certik, Bohuslav Baxa, Jan Antibiotics (Basel) Article Introduction: Vascular graft infection is a life threatening situation with significant morbidity and mortality. Bacterial graft infection can lead to false aneurysms, bleeding and sepsis. There are a lot of risky situations where grafts can become infected. It is therefore highly desirable to have a vascular graft that is resistant to infection. In this retrospective clinical study, a silver-impregnated vascular graft was evaluated in various indications. Methods: Our study included a total of 71 patients who received a silver-impregnated vascular graft during the period from 2013 to 2018. Patients had an aortoiliac localization of vascular graft in 61 cases (86%), and a peripheral localization on the lower limbs in 10 cases (14%). Indications for the use of these special vascular grafts were trophic lesions or gangrene in the lower limbs in 24 cases (34%), suspicious mycotic abdominal aortic aneurysm (mAAA) in 4 cases (5.5%), salmonela aortitis or aneurysms in 4 cases (5.5%), infection of the previous vascular graft in 11 cases (15.5%), other infections in 12 cases (17%), AAA rupture in 10 cases (14%) and other reasons (pre-transplant condition, multiple trauma, graft-enteric fistula) in 6 cases (8.5%). Thirty-day mortality, morbidity, the need for reintervention and amputation, primary and secondary graft patency, and finally the presence of a proven vascular graft infection were evaluated. Results: The 30-day mortality was 19.7%, and morbidity was 42.2%. The primary patency of the vascular graft was 91.5%. Reoperation was necessary in 10 cases (14%) and amputation was necessary in 10 cases (14%). The median length of hospital stay was 13 days and the mean follow-up period was 48 ± 9 months. During the follow-up period, six patients (8.5%) died from reasons unrelated to surgery or without any relation to the vascular graft. Secondary patency after one year was 88%. Infection of the silver graft was observed in three patients (4.2%). Conclusions: Based on our results, the silver graft is a very suitable alternative for solving infectious, or potentially infectious, situations in vascular surgery. In particular, in urgent or acute cases, a silver graft is often the only option. MDPI 2022-03-15 /pmc/articles/PMC8944627/ /pubmed/35326849 http://dx.doi.org/10.3390/antibiotics11030386 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Molacek, Jiri Treska, Vladislav Houdek, Karel Opatrný, Václav Certik, Bohuslav Baxa, Jan Use of a Silver-Impregnated Vascular Graft: Single-Center Experience |
title | Use of a Silver-Impregnated Vascular Graft: Single-Center Experience |
title_full | Use of a Silver-Impregnated Vascular Graft: Single-Center Experience |
title_fullStr | Use of a Silver-Impregnated Vascular Graft: Single-Center Experience |
title_full_unstemmed | Use of a Silver-Impregnated Vascular Graft: Single-Center Experience |
title_short | Use of a Silver-Impregnated Vascular Graft: Single-Center Experience |
title_sort | use of a silver-impregnated vascular graft: single-center experience |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8944627/ https://www.ncbi.nlm.nih.gov/pubmed/35326849 http://dx.doi.org/10.3390/antibiotics11030386 |
work_keys_str_mv | AT molacekjiri useofasilverimpregnatedvasculargraftsinglecenterexperience AT treskavladislav useofasilverimpregnatedvasculargraftsinglecenterexperience AT houdekkarel useofasilverimpregnatedvasculargraftsinglecenterexperience AT opatrnyvaclav useofasilverimpregnatedvasculargraftsinglecenterexperience AT certikbohuslav useofasilverimpregnatedvasculargraftsinglecenterexperience AT baxajan useofasilverimpregnatedvasculargraftsinglecenterexperience |